219 related articles for article (PubMed ID: 25499467)
1. Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis.
Lee PW; Yang Y; Racke MK; Lovett-Racke AE
Brain Behav Immun; 2015 May; 46():44-9. PubMed ID: 25499467
[TBL] [Abstract][Full Text] [Related]
2. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
3. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.
Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z
Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181
[TBL] [Abstract][Full Text] [Related]
4. The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis.
Xiao BG; Zhu WH; Lu CZ
Cell Immunol; 2007 Sep; 249(1):30-6. PubMed ID: 18061154
[TBL] [Abstract][Full Text] [Related]
5. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.
El-Behi M; Ciric B; Dai H; Yan Y; Cullimore M; Safavi F; Zhang GX; Dittel BN; Rostami A
Nat Immunol; 2011 Jun; 12(6):568-75. PubMed ID: 21516111
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of T
de Lima KA; Donate PB; Talbot J; Davoli-Ferreira M; Peres RS; Cunha TM; Alves-Filho JC; Cunha FQ
Cell Death Dis; 2018 Nov; 9(11):1130. PubMed ID: 30425241
[TBL] [Abstract][Full Text] [Related]
7. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
Bjarnadóttir K; Benkhoucha M; Merkler D; Weber MS; Payne NL; Bernard CCA; Molnarfi N; Lalive PH
Sci Rep; 2016 Oct; 6():34594. PubMed ID: 27708418
[TBL] [Abstract][Full Text] [Related]
8. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
[TBL] [Abstract][Full Text] [Related]
9. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882
[TBL] [Abstract][Full Text] [Related]
10. AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Mangalam AK; Rattan R; Suhail H; Singh J; Hoda MN; Deshpande M; Fulzele S; Denic A; Shridhar V; Kumar A; Viollet B; Rodriguez M; Giri S
J Immunol; 2016 Aug; 197(3):747-60. PubMed ID: 27354217
[TBL] [Abstract][Full Text] [Related]
11. IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.
Grifka-Walk HM; Giles DA; Segal BM
Eur J Immunol; 2015 Oct; 45(10):2780-6. PubMed ID: 26220255
[TBL] [Abstract][Full Text] [Related]
12. The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
Brüstle A; Brenner D; Knobbe CB; Lang PA; Virtanen C; Hershenfield BM; Reardon C; Lacher SM; Ruland J; Ohashi PS; Mak TW
J Clin Invest; 2012 Dec; 122(12):4698-709. PubMed ID: 23114599
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles for TGF-beta1 and TGF-beta3 isoforms in experimental autoimmune encephalomyelitis.
Matejuk A; Dwyer J; Hopke C; Vandenbark AA; Offner H
Cytokine; 2004 Jan; 25(2):45-51. PubMed ID: 14693159
[TBL] [Abstract][Full Text] [Related]
14. Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.
Oomizu S; Arikawa T; Niki T; Kadowaki T; Ueno M; Nishi N; Yamauchi A; Hirashima M
Clin Immunol; 2012 Apr; 143(1):51-8. PubMed ID: 22341088
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
[TBL] [Abstract][Full Text] [Related]
16. Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes T
Aqel SI; Kraus EE; Jena N; Kumari V; Granitto MC; Mao L; Farinas MF; Zhao EY; Perottino G; Pei W; Lovett-Racke AE; Racke MK; Fuchs JR; Li C; Yang Y
Clin Exp Immunol; 2019 May; 196(2):215-225. PubMed ID: 30615197
[TBL] [Abstract][Full Text] [Related]
17. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic function of bystander-activated memory-like CD4
Lee HG; Lee JU; Kim DH; Lim S; Kang I; Choi JM
Nat Commun; 2019 Feb; 10(1):709. PubMed ID: 30755603
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
20. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
